67 related articles for article (PubMed ID: 26791567)
1. Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
Yanagisawa T; Sato S; Hayashida Y; Okada Y; Matsukawa A; Iwatani K; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
Histopathology; 2024 Jul; 85(1):92-103. PubMed ID: 38477374
[TBL] [Abstract][Full Text] [Related]
2. Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas.
HacihasanoĞlu E; YÜcetaŞ U; OkÇu O; BehzatoĞlu K
Turk Patoloji Derg; 2021; 37(1):26-31. PubMed ID: 32692402
[TBL] [Abstract][Full Text] [Related]
3. Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients.
Orsola A; Werner L; de Torres I; Martin-Doyle W; Raventos CX; Lozano F; Mullane SA; Leow JJ; Barletta JA; Bellmunt J; Morote J
Br J Cancer; 2015 Feb; 112(3):468-74. PubMed ID: 25535728
[TBL] [Abstract][Full Text] [Related]
4. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer.
Lopez-Beltran A; Raspollini MR; Hansel D; Compérat E; Williamson SR; Liedberg F; Iczkowski KA; Bubendorf L; van der Kwast TH; Cheng L;
Am J Surg Pathol; 2024 Jan; 48(1):e24-e31. PubMed ID: 37737692
[TBL] [Abstract][Full Text] [Related]
5. T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis.
de Jong FC; Hoedemaeker RF; Kvikstad V; Mensink JTM; de Jong JJ; Boevé ER; van der Schoot DKE; Zwarthoff EC; Boormans JL; Zuiverloon TCM
J Urol; 2021 Mar; 205(3):701-708. PubMed ID: 33191862
[TBL] [Abstract][Full Text] [Related]
6. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients.
Valeri M; Contieri R; Fasulo V; Iuzzolino M; Cieri M; Elefante GM; De Carlo C; Bressan A; Saitta C; Gobbo A; Avolio PP; Dacrema V; Lazzeri M; Taverna G; Terracciano LM; Hurle R; Colombo P
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765894
[TBL] [Abstract][Full Text] [Related]
7. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
Lonati C; Afferi L; Mari A; Minervini A; Krajewski W; Borghesi M; Schulz GB; Rink M; Montorsi F; Briganti A; Colombo R; Martini A; Necchi A; Contieri R; Hurle R; Umari P; Zamboni S; Simeone C; Soria F; Marra G; Gontero P; Teoh JY; Klatte T; Bajeot AS; Roumiguié M; Rouprêt M; Masson-Lecomte A; Laukhtina E; Valiquette AS; Mir MC; Antonelli A; Einerhand SMH; Hendricksen K; Carando R; Fankhauser CD; Baumeister P; Mattei A; Shariat SF; Moschini M;
World J Urol; 2022 May; 40(5):1167-1174. PubMed ID: 35218372
[TBL] [Abstract][Full Text] [Related]
8. Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR).
Musat MG; Kwon CS; Masters E; Sikirica S; Pijush DB; Forsythe A
Clinicoecon Outcomes Res; 2022; 14():35-48. PubMed ID: 35046678
[TBL] [Abstract][Full Text] [Related]
9. Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View.
Mazzucchelli R; Marzioni D; Tossetta G; Pepi L; Montironi R
Front Surg; 2021; 8():754741. PubMed ID: 34926567
[TBL] [Abstract][Full Text] [Related]
10. Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience.
Paciotti M; Casale P; Colombo P; Fasulo V; Saita A; Lughezzani G; Contieri R; Buffi NM; Lazzeri M; Guazzoni G; Hurle R
Eur Urol Open Sci; 2021 Apr; 26():64-71. PubMed ID: 34337509
[TBL] [Abstract][Full Text] [Related]
11. Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.
Turan T; Efiloğlu Ö; Günaydin B; Özkanli Ş; Nikerel E; Atiş G; Çaşkurlu T; Yildirim A
Int Braz J Urol; 2018; 44(2):267-272. PubMed ID: 29219283
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
Patriarca C; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Guazzoni G; Conti A; Conti G; Lucianò R; Magnani T; Colombo R
Diagn Pathol; 2016 Jan; 11():6. PubMed ID: 26791567
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
[TBL] [Abstract][Full Text] [Related]
15. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Lawless M; Gulati R; Tretiakova M
Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
Paner GP; Montironi R; Amin MB
Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
